杨洪屈园园马红艳普雄明胡凤侠.胸腺五肽联合干扰素治疗慢性湿疹的疗效观察[J].现代生物医学进展英文版,2014,14(2):300-301. |
胸腺五肽联合干扰素治疗慢性湿疹的疗效观察 |
Clinical Observation on the Efficacy of Thymopoietin-5 and Interferon in theTreatment of Chronic Eczema |
|
DOI: |
中文关键词: 胸腺五肽 干扰素 慢性湿疹 疗效 |
英文关键词: Thymopoietin-5 Interferon Chronic eczema Efficacy |
基金项目: |
|
Hits: 727 |
Download times: 1088 |
中文摘要: |
摘要目的:探讨胸腺五肽联合干扰素治疗慢性湿疹的临床效果及安全性。方法:随机将2009~2012 年我科收治的60 例慢性湿
疹患者分为两组,治疗组30 例在给予相应的抗组胺药、非特异性抗过敏治疗的基础上加用胸腺五肽针10 mg 与干扰素琢-2b 200
万U交替肌注,对照组30 例只给予抗组胺药、非特异性抗过敏治疗,两组均在3 周后观察其治疗效果及不良反应的发生情况。结
果:治疗三周后,治疗组总有效率为70%,对照组总有效率为33.33%,两组总有效率比较差异有统计学意义(P<0.05)。两组不良反
应的发生率比较并无统计学差异(P>0.05)。结论:胸腺五肽联合干扰素治疗慢性湿疹的临床疗效显著,副作用较小,安全性较高,
值得临床推广应用。 |
英文摘要: |
ABSTRACT Objective:To explore the clinical efficacy and safety of thymopoietin-5 combined with interferon in the treatment of
chronic eczema. Methods:60 cases with chronic eczema hospitalized in our department from 2009 to 2012 were randomly divided into
two groups, 30 cases in the treatment group were treated with antihistamines, non-specific anti-allergic therapy as well as alternating
injection of thymopoietin-5 10mg/day and interferon α-2b 2× 106 U/day. 30 cases in the control group were only given antihistamines,
non-specific anti-allergic therapy. The clinical efficacy and adverse effects were observed after three weeks.Results: Three weeks after
treatment, the total effective rate of treatment group was 70%, which was significantly higher than that in the control group (33.33%, P<
0.05). No significant difference of incidence of adverse reactions was observed between the two groups (P>0.05).Conclusion:
Thymopoietin-5 plus interferon was effective and safe in the treatment of chronic eczema, it was showed good efficacy with little adverse
effect and worth being further widely popularized in clinic. |
View Full Text
View/Add Comment Download reader |
Close |